ImportRefusal LogoImportRefusal

Mylan Laboratories Limited

⚠️ High Risk

FEI: 3010453141 • District Dhar, Madhya Pradesh • INDIA

FEI

FEI Number

3010453141

📍

Location

District Dhar, Madhya Pradesh

🇮🇳

Country

INDIA
🏢

Address

(FDF-3) Plot Nos. 11, 12, 13, Indore SEZ, Pharma Zone, Phase II, Sector III, Pithampur, District Dhar, Madhya Pradesh, India

High Risk

FDA Import Risk Assessment

62.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

7
Total Refusals
2
Unique Violations
4/8/2025
Latest Refusal
9/15/2021
Earliest Refusal

Score Breakdown

Violation Severity
84.3×40%
Refusal Volume
33.5×30%
Recency
84.8×20%
Frequency
19.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

755×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3312×

DR QUALITC

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the drug appears to be represented as not being recognized in an official compendium and appears its strength differs from or its quality or purity falls below, that which it purports or is represented to possess.

Refusal History

DateProductViolationsDivision
4/8/2025
66JCA01LEVOTHYROXINE SODIUM (THYROID HORMONE)
331DR QUALITC
Division of Southeast Imports (DSEI)
3/13/2025
66JCA01LEVOTHYROXINE SODIUM (THYROID HORMONE)
331DR QUALITC
Division of Southeast Imports (DSEI)
1/21/2025
62VCY15TENOFOVIR DISOPROXIL FUMERATE
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/16/2024
62VDA99ANTI-VIRAL N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/17/2023
62VDY73DOLUTEGRAVIR SODIUM (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/25/2022
62VDY77EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/15/2021
62VDB15TENOFOVIR DISOPROXIL FUMERATE
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Mylan Laboratories Limited's FDA import refusal history?

Mylan Laboratories Limited (FEI: 3010453141) has 7 FDA import refusal record(s) in our database, spanning from 9/15/2021 to 4/8/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Mylan Laboratories Limited's FEI number is 3010453141.

What types of violations has Mylan Laboratories Limited received?

Mylan Laboratories Limited has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Mylan Laboratories Limited come from?

All FDA import refusal data for Mylan Laboratories Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.